‘Unprecedented achievement’ provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway

Innovations in rehabilitative walking devices, transparent sensors and actuators, conditioning for tissue transplants, microfluidic systems, retrievable information storage using nucleic acids, and more

10 key takeaways from OTD’s Bench-to-Business Boot Camp

Agreement enables development of genome-based therapies to protect against heart disease in adults